Alkermes Plc. (ALKS)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Richard F. Pops
Employees:
2,210
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, IRELAND 00000
00-353-1-772-8000

Alkermes plc researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; VIVITROL, and VUMERITY. The company is also developing LYBALVI, an oral atypical antipsychotic drug candidate.

Data derived from most recent annual or quarterly report
Market Cap 4.231 Billion Shares Outstanding164.312 Million Avg 30-day Volume 1.048 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.97
Price to Revenue3.8436 Debt to Equity0.281 EBITDA-84.031 Million
Price to Book Value4.0942 Operating Margin-12.796 Enterprise Value3.827 Billion
Current Ratio2.271 EPS Growth-2.233 Quick Ratio1.801
1 Yr BETA 0.524 52-week High/Low 32.79 / 21.75 Profit Margin-14.2353
Operating Cash Flow Growth-79.3108 Altman Z-Score2.2555 Free Cash Flow to Firm -53.887 Million
Earnings Report2023-04-26
View SEC Filings from ALKS instead.

View recent insider trading info

Alkermes Plc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding ALKS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ALKS

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-02-22 by POPS RICHARD F
  • 4: filed on 2023-02-22 by LANDINE MICHAEL J
  • 4: filed on 2023-02-22 by JACKSON BLAIR CURTIS
  • 4: filed on 2023-02-22 by HOPKINSON CRAIG C.
  • 4: filed on 2023-02-22 by GAFFIN DAVID JOSEPH
  • 4: filed on 2023-02-22 by BROWN IAIN MICHAEL
  • 4: filed on 2022-12-09 by LAURENCIN CATO T
  • 4: filed on 2022-11-16 by DAGLIO DAVID ANGELO JR.
  • 4: filed on 2022-08-05 by GAFFIN DAVID JOSEPH
  • 4: filed on 2022-07-08 by WYSENSKI NANCY

    • Events (8k)

  • 8-K: filed on 2023-02-16:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-06:
    Item 8.01: Other Events
  • 8-K: filed on 2023-01-09:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-06:
    Item 8.01: Other Events
  • 8-K: filed on 2022-11-15:
    Item 8.01: Other Events
  • 8-K: filed on 2022-11-02:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-19:
    Item 8.01: Other Events
  • 8-K: filed on 2022-07-27:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-07:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-27:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    194.8 Thousand total shares from 26 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    POPS RICHARD F DIRECTOR AND CEO, ALKERMES PLC

    • Officer
    • Director
    		 0 2023-02-23 3

    LANDINE MICHAEL J SVP, CORP DEV., ALKERMES, INC.

    • Officer
    		 250,442 2023-02-22 5

    BROWN IAIN MICHAEL SVP, CHIEF FINANCIAL OFFICER

    • Officer
    		 82,838 2023-02-22 2

    GAFFIN DAVID JOSEPH EVP, CLO, ALKERMES, INC.

    • Officer
    		 126,853 2023-02-22 3

    HOPKINSON CRAIG C. EVP R&D, CHIEF MEDICAL OFFICER

    • Officer
    		 56,559 2023-02-22 2

    NICHOLS CHRISTIAN TODD SVP, CHIEF COMMERCIAL OFFICER

    • Officer
    		 48,484 2023-02-22 4

    JACKSON BLAIR CURTIS EVP, CHIEF OPERATING OFFICER

    • Officer
    		 114,117 2023-02-22 3

    MCKEON BRIAN P

    • Director
    		 25,169 2023-02-10 3

    DAGLIO DAVID ANGELO JR.

    • Director
    		 95,169 2023-02-10 4

    LAURENCIN CATO T

    • Director
    		 15,642 2022-12-08 2

    WYSENSKI NANCY

    • Director
    		 17,511 2022-07-07 2

    WILSON FRANK ANDERS

    • Director
    		 17,511 2022-07-07 2

    COOKE SHANE

    • Director
    		 17,511 2022-07-07 7

    SNYDERMAN NANCY LYNN MD

    • Director
    		 17,511 2022-07-07 2

    ALVA EMILY PETERSON

    • Director
    		 17,511 2022-07-07 3

    GAYNOR RICHARD

    • Director
    		 17,511 2022-07-07 2

    WRIGHT CHRISTOPHER I

    • Director
    		 17,511 2022-07-07 3

    ANSTICE DAVID W

    • Director
    		 84,905 2022-06-14 1

    DIXON WENDY L

    • Director
    		 53,124 2022-06-14 1

    BREYER ROBERT A

    • Director
    		 10,330 2021-05-20 0

    MITCHELL PAUL J

    • Director
    		 18,174 2021-05-20 0

    FRATES JAMES M SVP, ALKS INC; CFO ALKS

    • Officer
    		 247,497 2020-05-14 0

    BLOOM FLOYD E

    • Director
    		 0 2019-05-22 0

    ROBINSON JAMES A. JR. PRESIDENT & COO,ALKERMES, INC.

    • Officer
    		 4,412 2019-04-04 0

    BIBERSTEIN KATHRYN L EVP/CAO/CCO/CRO ALKS INC;

    • Officer
    		 182,073 2018-03-01 0

    STEJBACH MARK SVP/CHIEF COMM OFF, ALKS INC

    • Officer
    		 51,065 2018-03-01 0

    EHRICH ELLIOT EVP, R&D & CMO, ALKERMES, INC.

    • Officer
    		 57,056 2017-05-28 0

    PUGH GORDON G SVP, COO & CRO, ALKERMES, INC.

    • Officer
    		 No longer subject to file 2016-12-31 0

    PETERSON REBECCA SVP, CORPORATE COMMUNICATIONS

    • Officer
    		 2,644 2015-10-05 0

    HENWOOD GERALDINE

    • Director
    		 0 2014-05-28 0

    BOTKIN JAMES L SVP, ALKERMES GAINESVILLE LLC

    • Officer
    		 No longer subject to file 2013-12-31 0

    SKALETSKY MARK B

    • Director
    		 No longer subject to file 2013-11-13 0

    ELAN CORP PLC

    ELAN SCIENCE THREE LTD

    • 10% Owner
    		 No longer subject to file 2012-03-13 0

    RICH ALEXANDER

    • Director
    		 No longer subject to file 2011-09-16 0

    WALL MICHAEL A

    • Director
    		 No longer subject to file 2011-09-16 0

    BROECKER DAVID A PRESIDENT & CEO

    • Officer
    		 106,616 2009-06-16 0

    SCHIMMEL PAUL

    • Director
    		 360,600 2007-06-15 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    POPS RICHARD F - Director - Officer DIRECTOR AND CEO, ALKERMES PLC

    		2023-02-24 20:26:49 -0500 2023-02-23 A 284,873 a 284,873 direct

    LANDINE MICHAEL J - Officer SVP, CORP DEV., ALKERMES, INC.

    		2023-02-24 20:25:03 -0500 2023-02-23 A 15,991 a 15,991 direct

    LANDINE MICHAEL J - Officer SVP, CORP DEV., ALKERMES, INC.

    		2023-02-24 20:25:03 -0500 2023-02-23 A 63,962 a 63,962 direct

    BROWN IAIN MICHAEL - Officer SVP, CHIEF FINANCIAL OFFICER

    		2023-02-24 20:19:48 -0500 2023-02-23 A 22,844 a 22,844 direct

    BROWN IAIN MICHAEL - Officer SVP, CHIEF FINANCIAL OFFICER

    		2023-02-24 20:19:48 -0500 2023-02-23 A 91,375 a 91,375 direct

    GAFFIN DAVID JOSEPH - Officer EVP, CLO, ALKERMES, INC.

    		2023-02-24 20:21:34 -0500 2023-02-23 A 30,154 a 30,154 direct

    GAFFIN DAVID JOSEPH - Officer EVP, CLO, ALKERMES, INC.

    		2023-02-24 20:21:34 -0500 2023-02-23 A 120,615 a 120,615 direct

    HOPKINSON CRAIG C. - Officer EVP R&D, CHIEF MEDICAL OFFICER

    		2023-02-24 20:23:13 -0500 2023-02-23 A 30,154 a 30,154 direct

    HOPKINSON CRAIG C. - Officer EVP R&D, CHIEF MEDICAL OFFICER

    		2023-02-24 20:23:13 -0500 2023-02-23 A 120,615 a 120,615 direct

    JACKSON BLAIR CURTIS - Officer EVP, CHIEF OPERATING OFFICER

    		2023-02-24 20:24:06 -0500 2023-02-23 A 34,266 a 34,266 direct

    JACKSON BLAIR CURTIS - Officer EVP, CHIEF OPERATING OFFICER

    		2023-02-24 20:24:06 -0500 2023-02-23 A 137,062 a 137,062 direct

    NICHOLS CHRISTIAN TODD - Officer SVP, CHIEF COMMERCIAL OFFICER

    		2023-02-24 20:25:46 -0500 2023-02-23 A 25,128 a 25,128 direct

    NICHOLS CHRISTIAN TODD - Officer SVP, CHIEF COMMERCIAL OFFICER

    		2023-02-24 20:25:46 -0500 2023-02-23 A 100,512 a 100,512 direct

    LANDINE MICHAEL J - Officer SVP, CORP DEV., ALKERMES, INC.

    		2023-02-24 20:25:03 -0500 2023-02-22 F 2,462 $27.77 d 250,442 direct -1.655 0.1103 0.6988 3 -1.655 2

    LANDINE MICHAEL J - Officer SVP, CORP DEV., ALKERMES, INC.

    		2023-02-24 20:25:03 -0500 2023-02-22 M 5,544 a 252,904 direct -1.655 0.1103 0.6988 3 -1.655 2

    LANDINE MICHAEL J - Officer SVP, CORP DEV., ALKERMES, INC.

    		2023-02-24 20:25:03 -0500 2023-02-22 M 5,544 d 11,088 direct

    BROWN IAIN MICHAEL - Officer SVP, CHIEF FINANCIAL OFFICER

    		2023-02-24 20:19:48 -0500 2023-02-22 F 2,049 $27.77 d 82,838 direct -1.655 0.1103 0.6988 3 -1.655 2

    BROWN IAIN MICHAEL - Officer SVP, CHIEF FINANCIAL OFFICER

    		2023-02-24 20:19:48 -0500 2023-02-22 M 6,969 a 84,887 direct -1.655 0.1103 0.6988 3 -1.655 2

    BROWN IAIN MICHAEL - Officer SVP, CHIEF FINANCIAL OFFICER

    		2023-02-24 20:19:48 -0500 2023-02-22 M 6,969 d 13,939 direct

    GAFFIN DAVID JOSEPH - Officer EVP, CLO, ALKERMES, INC.

    		2023-02-24 20:21:34 -0500 2023-02-22 F 3,224 $27.77 d 126,853 direct -1.655 0.1103 0.6988 3 -1.655 2

    GAFFIN DAVID JOSEPH - Officer EVP, CLO, ALKERMES, INC.

    		2023-02-24 20:21:34 -0500 2023-02-22 M 7,286 a 130,077 direct -1.655 0.1103 0.6988 3 -1.655 2

    GAFFIN DAVID JOSEPH - Officer EVP, CLO, ALKERMES, INC.

    		2023-02-24 20:21:34 -0500 2023-02-22 M 7,286 d 14,572 direct

    HOPKINSON CRAIG C. - Officer EVP R&D, CHIEF MEDICAL OFFICER

    		2023-02-24 20:23:13 -0500 2023-02-22 F 5,345 $27.77 d 56,559 direct -1.655 0.1103 0.6988 3 -1.655 2

    HOPKINSON CRAIG C. - Officer EVP R&D, CHIEF MEDICAL OFFICER

    		2023-02-24 20:23:13 -0500 2023-02-22 M 12,038 a 61,904 direct -1.655 0.1103 0.6988 3 -1.655 2

    HOPKINSON CRAIG C. - Officer EVP R&D, CHIEF MEDICAL OFFICER

    		2023-02-24 20:23:13 -0500 2023-02-22 M 12,038 d 24,076 direct

    JACKSON BLAIR CURTIS - Officer EVP, CHIEF OPERATING OFFICER

    		2023-02-24 20:24:06 -0500 2023-02-22 F 3,088 $27.77 d 114,117 direct -1.655 0.1103 0.6988 3 -1.655 2

    JACKSON BLAIR CURTIS - Officer EVP, CHIEF OPERATING OFFICER

    		2023-02-24 20:24:06 -0500 2023-02-22 M 9,504 a 117,205 direct -1.655 0.1103 0.6988 3 -1.655 2

    JACKSON BLAIR CURTIS - Officer EVP, CHIEF OPERATING OFFICER

    		2023-02-24 20:24:06 -0500 2023-02-22 M 9,504 d 19,007 direct

    NICHOLS CHRISTIAN TODD - Officer SVP, CHIEF COMMERCIAL OFFICER

    		2023-02-24 20:25:46 -0500 2023-02-22 F 2,704 $27.77 d 48,484 direct -1.655 0.1103 0.6988 3 -1.655 2

    NICHOLS CHRISTIAN TODD - Officer SVP, CHIEF COMMERCIAL OFFICER

    		2023-02-24 20:25:46 -0500 2023-02-22 M 6,969 a 51,188 direct -1.655 0.1103 0.6988 3 -1.655 2

    NICHOLS CHRISTIAN TODD - Officer SVP, CHIEF COMMERCIAL OFFICER

    		2023-02-24 20:25:46 -0500 2023-02-22 M 6,969 d 13,939 direct

    BROWN IAIN MICHAEL - Officer SVP, CHIEF FINANCIAL OFFICER

    		2023-02-22 16:54:03 -0500 2023-02-21 F 1,412 $27.77 d 77,918 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    BROWN IAIN MICHAEL - Officer SVP, CHIEF FINANCIAL OFFICER

    		2023-02-22 16:54:03 -0500 2023-02-21 M 4,800 a 79,330 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    BROWN IAIN MICHAEL - Officer SVP, CHIEF FINANCIAL OFFICER

    		2023-02-22 16:54:03 -0500 2023-02-21 M 4,800 d 0 direct

    HOPKINSON CRAIG C. - Officer EVP R&D, CHIEF MEDICAL OFFICER

    		2023-02-22 16:56:07 -0500 2023-02-21 F 3,053 $27.77 d 49,866 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    HOPKINSON CRAIG C. - Officer EVP R&D, CHIEF MEDICAL OFFICER

    		2023-02-22 16:56:07 -0500 2023-02-21 M 6,875 a 52,919 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    HOPKINSON CRAIG C. - Officer EVP R&D, CHIEF MEDICAL OFFICER

    		2023-02-22 16:56:07 -0500 2023-02-21 M 6,875 d 0 direct

    LANDINE MICHAEL J - Officer SVP, CORP DEV., ALKERMES, INC.

    		2023-02-22 16:58:36 -0500 2023-02-21 F 2,587 $27.77 d 247,360 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    LANDINE MICHAEL J - Officer SVP, CORP DEV., ALKERMES, INC.

    		2023-02-22 16:58:36 -0500 2023-02-21 M 5,825 a 249,947 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    LANDINE MICHAEL J - Officer SVP, CORP DEV., ALKERMES, INC.

    		2023-02-22 16:58:36 -0500 2023-02-21 M 5,825 d 0 direct

    JACKSON BLAIR CURTIS - Officer EVP, CHIEF OPERATING OFFICER

    		2023-02-22 16:57:10 -0500 2023-02-21 F 1,412 $27.77 d 107,701 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    JACKSON BLAIR CURTIS - Officer EVP, CHIEF OPERATING OFFICER

    		2023-02-22 16:57:10 -0500 2023-02-21 M 4,800 a 109,113 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    JACKSON BLAIR CURTIS - Officer EVP, CHIEF OPERATING OFFICER

    		2023-02-22 16:57:10 -0500 2023-02-21 M 4,800 d 0 direct

    POPS RICHARD F - Director - Officer DIRECTOR AND CEO, ALKERMES PLC

    		2023-02-22 17:00:31 -0500 2023-02-21 F 14,386 $27.77 d 1,052,881 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    POPS RICHARD F - Director - Officer DIRECTOR AND CEO, ALKERMES PLC

    		2023-02-22 17:00:31 -0500 2023-02-21 M 32,400 a 1,067,267 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    POPS RICHARD F - Director - Officer DIRECTOR AND CEO, ALKERMES PLC

    		2023-02-22 17:00:31 -0500 2023-02-21 M 32,400 d 0 direct

    GAFFIN DAVID JOSEPH - Officer EVP, CLO, ALKERMES, INC.

    		2023-02-22 16:55:23 -0500 2023-02-21 F 2,022 $27.77 d 122,791 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    GAFFIN DAVID JOSEPH - Officer EVP, CLO, ALKERMES, INC.

    		2023-02-22 16:55:23 -0500 2023-02-21 M 6,875 a 124,813 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    GAFFIN DAVID JOSEPH - Officer EVP, CLO, ALKERMES, INC.

    		2023-02-22 16:55:23 -0500 2023-02-21 M 6,875 d 0 direct

    BROWN IAIN MICHAEL - Officer SVP, CHIEF FINANCIAL OFFICER

    		2023-02-22 16:54:03 -0500 2023-02-20 F 1,350 $28.07 d 67,410 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    BROWN IAIN MICHAEL - Officer SVP, CHIEF FINANCIAL OFFICER

    		2023-02-22 16:54:03 -0500 2023-02-20 F 2,966 $28.07 d 74,530 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    BROWN IAIN MICHAEL - Officer SVP, CHIEF FINANCIAL OFFICER

    		2023-02-22 16:54:03 -0500 2023-02-20 M 4,589 a 68,760 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    BROWN IAIN MICHAEL - Officer SVP, CHIEF FINANCIAL OFFICER

    		2023-02-22 16:54:03 -0500 2023-02-20 M 4,589 d 4,589 direct

    BROWN IAIN MICHAEL - Officer SVP, CHIEF FINANCIAL OFFICER

    		2023-02-22 16:54:03 -0500 2023-02-20 A 10,086 a 77,496 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    HOPKINSON CRAIG C. - Officer EVP R&D, CHIEF MEDICAL OFFICER

    		2023-02-22 16:56:07 -0500 2023-02-20 F 3,780 $28.07 d 30,375 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    HOPKINSON CRAIG C. - Officer EVP R&D, CHIEF MEDICAL OFFICER

    		2023-02-22 16:56:07 -0500 2023-02-20 F 6,526 $28.07 d 46,044 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    HOPKINSON CRAIG C. - Officer EVP R&D, CHIEF MEDICAL OFFICER

    		2023-02-22 16:56:07 -0500 2023-02-20 M 10,095 a 34,155 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    HOPKINSON CRAIG C. - Officer EVP R&D, CHIEF MEDICAL OFFICER

    		2023-02-22 16:56:07 -0500 2023-02-20 M 10,095 d 10,096 direct

    HOPKINSON CRAIG C. - Officer EVP R&D, CHIEF MEDICAL OFFICER

    		2023-02-22 16:56:07 -0500 2023-02-20 A 22,195 a 52,570 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    LANDINE MICHAEL J - Officer SVP, CORP DEV., ALKERMES, INC.

    		2023-02-22 16:58:36 -0500 2023-02-20 F 2,378 $28.07 d 237,578 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    LANDINE MICHAEL J - Officer SVP, CORP DEV., ALKERMES, INC.

    		2023-02-22 16:58:36 -0500 2023-02-20 F 5,226 $28.07 d 244,122 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    LANDINE MICHAEL J - Officer SVP, CORP DEV., ALKERMES, INC.

    		2023-02-22 16:58:36 -0500 2023-02-20 M 5,354 a 239,956 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    LANDINE MICHAEL J - Officer SVP, CORP DEV., ALKERMES, INC.

    		2023-02-22 16:58:36 -0500 2023-02-20 M 5,354 d 5,354 direct

    LANDINE MICHAEL J - Officer SVP, CORP DEV., ALKERMES, INC.

    		2023-02-22 16:58:36 -0500 2023-02-20 A 11,770 a 249,348 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    JACKSON BLAIR CURTIS - Officer EVP, CHIEF OPERATING OFFICER

    		2023-02-22 16:57:10 -0500 2023-02-20 F 1,350 $28.07 d 97,193 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    JACKSON BLAIR CURTIS - Officer EVP, CHIEF OPERATING OFFICER

    		2023-02-22 16:57:10 -0500 2023-02-20 F 2,966 $28.07 d 104,313 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    JACKSON BLAIR CURTIS - Officer EVP, CHIEF OPERATING OFFICER

    		2023-02-22 16:57:10 -0500 2023-02-20 M 4,589 a 98,543 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    JACKSON BLAIR CURTIS - Officer EVP, CHIEF OPERATING OFFICER

    		2023-02-22 16:57:10 -0500 2023-02-20 M 4,589 d 4,589 direct

    JACKSON BLAIR CURTIS - Officer EVP, CHIEF OPERATING OFFICER

    		2023-02-22 16:57:10 -0500 2023-02-20 A 10,086 a 107,279 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    NICHOLS CHRISTIAN TODD - Officer SVP, CHIEF COMMERCIAL OFFICER

    		2023-02-22 16:59:42 -0500 2023-02-20 F 1,125 $28.07 d 28,003 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    NICHOLS CHRISTIAN TODD - Officer SVP, CHIEF COMMERCIAL OFFICER

    		2023-02-22 16:59:42 -0500 2023-02-20 M 3,824 a 29,128 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    NICHOLS CHRISTIAN TODD - Officer SVP, CHIEF COMMERCIAL OFFICER

    		2023-02-22 16:59:42 -0500 2023-02-20 M 3,824 d 3,825 direct

    NICHOLS CHRISTIAN TODD - Officer SVP, CHIEF COMMERCIAL OFFICER

    		2023-02-22 16:59:42 -0500 2023-02-20 F 6,753 $28.07 d 44,219 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    NICHOLS CHRISTIAN TODD - Officer SVP, CHIEF COMMERCIAL OFFICER

    		2023-02-22 16:59:42 -0500 2023-02-20 A 22,969 a 50,972 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    POPS RICHARD F - Director - Officer DIRECTOR AND CEO, ALKERMES PLC

    		2023-02-22 17:00:31 -0500 2023-02-20 F 53,145 $28.07 d 1,034,867 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    POPS RICHARD F - Director - Officer DIRECTOR AND CEO, ALKERMES PLC

    		2023-02-22 17:00:31 -0500 2023-02-20 A 119,713 a 1,088,012 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    GAFFIN DAVID JOSEPH - Officer EVP, CLO, ALKERMES, INC.

    		2023-02-22 16:55:23 -0500 2023-02-20 F 2,069 $28.07 d 107,018 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    GAFFIN DAVID JOSEPH - Officer EVP, CLO, ALKERMES, INC.

    		2023-02-22 16:55:23 -0500 2023-02-20 F 4,548 $28.07 d 117,938 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    GAFFIN DAVID JOSEPH - Officer EVP, CLO, ALKERMES, INC.

    		2023-02-22 16:55:23 -0500 2023-02-20 M 7,036 a 109,087 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    GAFFIN DAVID JOSEPH - Officer EVP, CLO, ALKERMES, INC.

    		2023-02-22 16:55:23 -0500 2023-02-20 M 7,036 d 7,037 direct

    GAFFIN DAVID JOSEPH - Officer EVP, CLO, ALKERMES, INC.

    		2023-02-22 16:55:23 -0500 2023-02-20 A 15,468 a 122,486 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    BROWN IAIN MICHAEL - Officer SVP, CHIEF FINANCIAL OFFICER

    		2023-02-22 16:54:03 -0500 2023-02-18 F 1,965 $28.07 d 64,171 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    BROWN IAIN MICHAEL - Officer SVP, CHIEF FINANCIAL OFFICER

    		2023-02-22 16:54:03 -0500 2023-02-18 M 6,230 a 66,136 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    BROWN IAIN MICHAEL - Officer SVP, CHIEF FINANCIAL OFFICER

    		2023-02-22 16:54:03 -0500 2023-02-18 M 6,230 d 18,691 direct

    HOPKINSON CRAIG C. - Officer EVP R&D, CHIEF MEDICAL OFFICER

    		2023-02-22 16:56:07 -0500 2023-02-18 F 2,656 $28.07 d 24,060 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    HOPKINSON CRAIG C. - Officer EVP R&D, CHIEF MEDICAL OFFICER

    		2023-02-22 16:56:07 -0500 2023-02-18 M 8,722 a 26,716 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    HOPKINSON CRAIG C. - Officer EVP R&D, CHIEF MEDICAL OFFICER

    		2023-02-22 16:56:07 -0500 2023-02-18 M 8,722 d 26,167 direct

    LANDINE MICHAEL J - Officer SVP, CORP DEV., ALKERMES, INC.

    		2023-02-22 16:58:36 -0500 2023-02-18 F 2,065 $28.07 d 234,602 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    LANDINE MICHAEL J - Officer SVP, CORP DEV., ALKERMES, INC.

    		2023-02-22 16:58:36 -0500 2023-02-18 M 4,361 a 236,667 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    LANDINE MICHAEL J - Officer SVP, CORP DEV., ALKERMES, INC.

    		2023-02-22 16:58:36 -0500 2023-02-18 M 4,361 d 13,084 direct

    JACKSON BLAIR CURTIS - Officer EVP, CHIEF OPERATING OFFICER

    		2023-02-22 16:57:10 -0500 2023-02-18 F 2,683 $28.07 d 93,954 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    JACKSON BLAIR CURTIS - Officer EVP, CHIEF OPERATING OFFICER

    		2023-02-22 16:57:10 -0500 2023-02-18 M 8,722 a 96,637 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    JACKSON BLAIR CURTIS - Officer EVP, CHIEF OPERATING OFFICER

    		2023-02-22 16:57:10 -0500 2023-02-18 M 8,722 d 26,167 direct

    NICHOLS CHRISTIAN TODD - Officer SVP, CHIEF COMMERCIAL OFFICER

    		2023-02-22 16:59:42 -0500 2023-02-18 F 1,961 $28.07 d 25,304 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    NICHOLS CHRISTIAN TODD - Officer SVP, CHIEF COMMERCIAL OFFICER

    		2023-02-22 16:59:42 -0500 2023-02-18 M 6,230 a 27,265 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    NICHOLS CHRISTIAN TODD - Officer SVP, CHIEF COMMERCIAL OFFICER

    		2023-02-22 16:59:42 -0500 2023-02-18 M 6,230 d 18,691 direct

    GAFFIN DAVID JOSEPH - Officer EVP, CLO, ALKERMES, INC.

    		2023-02-22 16:55:23 -0500 2023-02-18 F 1,945 $28.07 d 102,051 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    GAFFIN DAVID JOSEPH - Officer EVP, CLO, ALKERMES, INC.

    		2023-02-22 16:55:23 -0500 2023-02-18 M 6,230 a 103,996 direct -0.6579 -0.6213 0.0731 5 -2.2661 4

    GAFFIN DAVID JOSEPH - Officer EVP, CLO, ALKERMES, INC.

    		2023-02-22 16:55:23 -0500 2023-02-18 M 6,230 d 18,691 direct

    MCKEON BRIAN P - Director

    		2023-02-10 20:03:13 -0500 2023-02-10 M 4,445 a 15,169 direct -0.0722 0.2889 1.7696 4 -2.528 3

    MCKEON BRIAN P - Director

    		2023-02-10 20:03:13 -0500 2023-02-10 M 4,445 d 4,445 direct

    DAGLIO DAVID ANGELO JR. - Director

    		2023-02-10 20:01:58 -0500 2023-02-10 M 4,445 a 15,169 direct -0.0722 0.2889 1.7696 4 -2.528 3

    DAGLIO DAVID ANGELO JR. - Director

    		2023-02-10 20:01:58 -0500 2023-02-10 M 4,445 d 4,445 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ALKERMES PLC ALKS 2023-03-24 16:15:03 UTC 4.57 0.25 4900000
    ALKERMES PLC ALKS 2023-03-24 15:45:03 UTC 4.57 0.25 4900000
    ALKERMES PLC ALKS 2023-03-24 15:15:03 UTC 4.57 0.25 5000000
    ALKERMES PLC ALKS 2023-03-24 14:45:03 UTC 4.32 0.25 5000000
    ALKERMES PLC ALKS 2023-03-24 14:15:03 UTC 4.32 0.25 4900000
    ALKERMES PLC ALKS 2023-03-24 13:45:03 UTC 4.32 0.25 4700000
    ALKERMES PLC ALKS 2023-03-24 13:15:04 UTC 4.32 0.25 4700000
    ALKERMES PLC ALKS 2023-03-24 12:45:03 UTC 4.32 0.25 4700000
    ALKERMES PLC ALKS 2023-03-23 22:15:04 UTC 4.32 0.25 5100000
    ALKERMES PLC ALKS 2023-03-23 21:45:04 UTC 4.32 0.25 5100000
    ALKERMES PLC ALKS 2023-03-23 21:15:04 UTC 4.32 0.25 5100000
    ALKERMES PLC ALKS 2023-03-23 20:45:03 UTC 4.32 0.25 5100000
    ALKERMES PLC ALKS 2023-03-23 20:15:03 UTC 4.32 0.25 5100000
    ALKERMES PLC ALKS 2023-03-23 19:45:03 UTC 4.32 0.25 5100000
    ALKERMES PLC ALKS 2023-03-23 19:15:03 UTC 4.32 0.25 5100000
    ALKERMES PLC ALKS 2023-03-23 18:45:04 UTC 4.32 0.25 5100000
    ALKERMES PLC ALKS 2023-03-23 18:15:03 UTC 4.32 0.25 5100000
    ALKERMES PLC ALKS 2023-03-23 17:45:03 UTC 4.32 0.25 5100000
    ALKERMES PLC ALKS 2023-03-23 17:15:03 UTC 4.32 0.25 5100000
    ALKERMES PLC ALKS 2023-03-23 16:45:04 UTC 4.1619 0.4081 5100000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    AGF Investments Trust- AGFIQ U.S. Market Neutral Momentum Fund ALKS -1284.0 shares, $-25615.8 2020-12-31 N-PORT
    FundVantage Trust- Gotham Master Neutral Fund ALKS -278.0 shares, $-4606.46 2020-09-30 N-PORT
    FundVantage Trust- Gotham Hedged Plus Fund ALKS -2332.0 shares, $-60935.16 2022-12-30 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments